FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4255257995> ?p ?o ?g. }

• W4255257995 abstract "Abstract Background Some antiretrovirals (ARVs) cause muscle toxicity and their use has been attributed to beginning of respiratory and peripheral muscle weakness in people living with HIV/AIDS (PLWHA) on treatment. Dolutegravir (DTG) has been adopted by Brazil as a first-line regimen with Tenofovir/Lamivudine (TDF/3TC) since 2017, with low toxicity profile. Due to the short use of this regimen, we have not found data in the literature regarding its effects in the respiratory and peripheral muscles in PLWHA. The aim of this study was to compare respiratory and peripheral muscle strength before and after start of this new combined ART (TDF/3TC/DTG).Methods Descriptive, longitudinal and prospective study, observational and analytical with 41 PLWHA evaluated before the initiation of antiretroviral therapy (ART) (T0) which of these, 28 were reevaluated after more than 50 days of treatment (T1).The assessments of maximum functional capacity (six-minute walk test distance), maximal inspiratory (MIP) and expiratory (MEP) pressures and handgrip strength (HGS) were performed using standardized methods. In addition, laboratory data (CD4, CD4/CD8 ratio and viral load-VL) were collected. Shapiro-Wilk test was applied for normality while Fisher's exact test and t-test or Wilcoxon test were used for comparisons of categorical and continuous variables, respectively. Pearson or Spearman correlations were used according to data normality and p-value < 0.05 were considered significant for all analyzes.Results The frequency of peripheral muscle weakness in patients evaluated at T0 was 97.6%, while 31.7% had inspiratory and / or expiratory muscle weakness. HGS was positively correlated with CD4 (p = 0.027) and negatively correlated with VL (p = 0.046). Both MIP (p = 0.0176) and HGS (p = 0.0018) showed improvement in T1.Conclusion ART combined with TDF / 3TC / DTG increased MIP and HGS after more than 50 days of treatment. Cohort studies are needed to better understand the action of these medications on PLWHA musculature under treatment." @default.
• W4255257995 created "2022-05-12" @default.
• W4255257995 creator A5006904341 @default.
• W4255257995 creator A5011468527 @default.
• W4255257995 creator A5027245266 @default.
• W4255257995 creator A5033076174 @default.
• W4255257995 creator A5044786935 @default.
• W4255257995 date "2019-10-04" @default.
• W4255257995 modified "2023-09-30" @default.
• W4255257995 title "Effect of Antiretroviral Therapy With Tenofovir, Lamivudine And Dolutegravir On Respiratory And Peripheral Muscles Strengh In People Living With Hiv/Aids" @default.
• W4255257995 doi "https://doi.org/10.21203/rs.2.15545/v1" @default.
• W4255257995 hasPublicationYear "2019" @default.
• W4255257995 type Work @default.
• W4255257995 citedByCount "0" @default.
• W4255257995 crossrefType "posted-content" @default.
• W4255257995 hasAuthorship W4255257995A5006904341 @default.
• W4255257995 hasAuthorship W4255257995A5011468527 @default.
• W4255257995 hasAuthorship W4255257995A5027245266 @default.
• W4255257995 hasAuthorship W4255257995A5033076174 @default.
• W4255257995 hasAuthorship W4255257995A5044786935 @default.
• W4255257995 hasBestOaLocation W42552579951 @default.
• W4255257995 hasConcept C126322002 @default.
• W4255257995 hasConcept C142462285 @default.
• W4255257995 hasConcept C159047783 @default.
• W4255257995 hasConcept C1862650 @default.
• W4255257995 hasConcept C2522874641 @default.
• W4255257995 hasConcept C2777869810 @default.
• W4255257995 hasConcept C2779502633 @default.
• W4255257995 hasConcept C2780593183 @default.
• W4255257995 hasConcept C2781413609 @default.
• W4255257995 hasConcept C2993143319 @default.
• W4255257995 hasConcept C3013748606 @default.
• W4255257995 hasConcept C71924100 @default.
• W4255257995 hasConceptScore W4255257995C126322002 @default.
• W4255257995 hasConceptScore W4255257995C142462285 @default.
• W4255257995 hasConceptScore W4255257995C159047783 @default.
• W4255257995 hasConceptScore W4255257995C1862650 @default.
• W4255257995 hasConceptScore W4255257995C2522874641 @default.
• W4255257995 hasConceptScore W4255257995C2777869810 @default.
• W4255257995 hasConceptScore W4255257995C2779502633 @default.
• W4255257995 hasConceptScore W4255257995C2780593183 @default.
• W4255257995 hasConceptScore W4255257995C2781413609 @default.
• W4255257995 hasConceptScore W4255257995C2993143319 @default.
• W4255257995 hasConceptScore W4255257995C3013748606 @default.
• W4255257995 hasConceptScore W4255257995C71924100 @default.
• W4255257995 hasLocation W42552579951 @default.
• W4255257995 hasOpenAccess W4255257995 @default.
• W4255257995 hasPrimaryLocation W42552579951 @default.
• W4255257995 hasRelatedWork W18329337 @default.
• W4255257995 hasRelatedWork W2522340 @default.
• W4255257995 hasRelatedWork W26565295 @default.
• W4255257995 hasRelatedWork W28391021 @default.
• W4255257995 hasRelatedWork W4351535 @default.
• W4255257995 hasRelatedWork W4429043 @default.
• W4255257995 hasRelatedWork W5062092 @default.
• W4255257995 hasRelatedWork W5346711 @default.
• W4255257995 hasRelatedWork W6339096 @default.
• W4255257995 hasRelatedWork W9134849 @default.
• W4255257995 isParatext "false" @default.
• W4255257995 isRetracted "false" @default.
• W4255257995 workType "article" @default.